Combinative interactions of a human immunodeficiency virus (HIV) Tat antagonist with HIV reverse transcriptase inhibitors and an HIV protease inhibitor

Antimicrobial Agents and Chemotherapy

Volumn 38, Issue 2, 1994, Pages 348-352

  Connell, E V ^a   Hsu, M C ^a   Richman, D D ^a  

^a HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; TRANSACTIVATOR PROTEIN; ZALCITABINE; ZIDOVUDINE;

ANTIBODY PRODUCTION; DRUG INHIBITION; DRUG POTENTIATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; PRIORITY JOURNAL;

EID: 0028008793     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.38.2.348     Document Type: Note

References (0)